EULAV Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.7M | Sell |
14,618
-34,600
| -70% | -$19.4M | 0.25% | 98 |
|
|
2026
Q1 | $27.7M | Sell |
49,218
-77,000
| -61% | -$49.4M | 0.89% | 37 |
|
|
2025
Q4 | $85.4M | Sell |
126,218
-2
| -0% | -$1.36K | 2.28% | 9 |
|
|
2025
Q3 | $80.6M | Buy |
126,220
+3
| +0% | +$1.82K | 1.87% | 13 |
|
|
2025
Q2 | $67.7M | Buy |
126,217
+2
| +0% | +$956 | 1.59% | 18 |
|
|
2025
Q1 | $53M | Buy |
126,215
+3
| +0% | +$1.3K | 1.31% | 25 |
|
|
2024
Q4 | $52.2M | Hold |
126,212
| – | – | 1.26% | 25 |
|
|
2024
Q3 | $63.8M | Hold |
126,212
| – | – | 1.55% | 19 |
|
|
2024
Q2 | $61.5M | Buy |
126,212
+6,197
| +5% | +$3.11M | 1.66% | 17 |
|
|
2024
Q1 | $64.8M | Buy |
120,015
+13,903
| +13% | +$7.6M | 1.78% | 14 |
|
|
2023
Q4 | $58.9M | Hold |
106,112
| – | – | 1.82% | 14 |
|
|
2023
Q3 | $46.4M | Sell |
106,112
-4,400
| -4% | -$2.19M | 1.7% | 10 |
|
|
2023
Q2 | $55.5M | Sell |
110,512
-8,588
| -7% | -$4.12M | 2.07% | 6 |
|
|
2023
Q1 | $59.6M | Buy |
119,100
+25,000
| +27% | +$12M | 2.35% | 5 |
|
|
2022
Q4 | $38.4M | Buy |
94,100
+32,900
| +54% | +$12.8M | 1.65% | 14 |
|
|
2022
Q3 | $19.9M | Hold |
61,200
| – | – | 0.88% | 36 |
|
|
2022
Q2 | $21.5M | Sell |
61,200
-19,800
| -24% | -$8.07M | 0.89% | 33 |
|
|
2022
Q1 | $44.3M | Sell |
81,000
-4
| -0% | -$2.1K | 1.32% | 21 |
|
|
2021
Q4 | $53.3M | Sell |
81,004
-13,200
| -14% | -$8.29M | 1.35% | 18 |
|
|
2021
Q3 | $58.6M | Hold |
94,204
| – | – | 1.55% | 13 |
|
|
2021
Q2 | $59.5M | Hold |
94,204
| – | – | 1.57% | 11 |
|
|
2021
Q1 | $46.1M | Sell |
94,204
-4,998
| -5% | -$2.5M | 1.24% | 22 |
|
|
2020
Q4 | $49.6M | Sell |
99,202
-9,998
| -9% | -$4.47M | 1.3% | 19 |
|
|
2020
Q3 | $42.9M | Hold |
109,200
| – | – | 1.27% | 20 |
|
|
2020
Q2 | $36.1M | Sell |
109,200
-48,900
| -31% | -$14.2M | 1.18% | 22 |
|
|
2020
Q1 | $38.3M | Hold |
158,100
| – | – | 1.53% | 13 |
|
|
2019
Q4 | $41.3M | Sell |
158,100
-16,100
| -9% | -$4.24M | 1.42% | 12 |
|
|
2019
Q3 | $47.4M | Sell |
174,200
-2,300
| -1% | -$640K | 1.75% | 7 |
|
|
2019
Q2 | $48.6M | Sell |
176,500
-1,200
| -0.7% | -$296K | 1.82% | 5 |
|
|
2019
Q1 | $40M | Hold |
177,700
| – | – | 1.65% | 7 |
|
|
2018
Q4 | $33.1M | Hold |
177,700
| – | – | 1.65% | 7 |
|
|
2018
Q3 | $44.4M | Sell |
177,700
-5,300
| -3% | -$1.29M | 1.9% | 2 |
|
|
2018
Q2 | $39.9M | Sell |
183,000
-20,300
| -10% | -$4.18M | 1.83% | 4 |
|
|
2018
Q1 | $38.9M | Sell |
203,300
-27,200
| -12% | -$5.02M | 1.86% | 5 |
|
|
2017
Q4 | $36M | Sell |
230,500
-6,900
| -3% | -$1.09M | 1.7% | 5 |
|
|
2017
Q3 | $36.9M | Hold |
237,400
| – | – | 1.74% | 4 |
|
|
2017
Q2 | $38.3M | Hold |
237,400
| – | – | 1.88% | 4 |
|
|
2017
Q1 | $36.7M | Hold |
237,400
| – | – | 1.87% | 3 |
|
|
2016
Q4 | $27.8M | Hold |
237,400
| – | – | 1.5% | 4 |
|
|
2016
Q3 | $26.8M | Hold |
237,400
| – | – | 1.42% | 5 |
|
|
2016
Q2 | $22M | Buy |
237,400
+1,000
| +0.4% | +$85.9K | 1.21% | 8 |
|
|
2016
Q1 | $18.5M | Buy |
236,400
+4,800
| +2% | +$346K | 1.03% | 14 |
|
|
2015
Q4 | $16.9M | Buy |
231,600
+1,000
| +0.4% | +$71.3K | 0.92% | 25 |
|
|
2015
Q3 | $17.1M | Buy |
230,600
+11,600
| +5% | +$831K | 0.97% | 16 |
|
|
2015
Q2 | $14M | Hold |
219,000
| – | – | 0.74% | 34 |
|
|
2015
Q1 | $16.9M | Buy |
219,000
+2,000
| +0.9% | +$156K | 0.87% | 16 |
|
|
2014
Q4 | $16.1M | Buy |
217,000
+46,400
| +27% | +$3.25M | 0.87% | 14 |
|
|
2014
Q3 | $10.1M | Hold |
170,600
| – | – | 0.55% | 61 |
|
|
2014
Q2 | $11.4M | Buy |
170,600
+7,600
| +5% | +$483K | 0.61% | 49 |
|
|
2014
Q1 | $9.89M | Sell |
163,000
-7,600
| -4% | -$453K | 0.54% | 65 |
|
|
2013
Q4 | $9.07M | Sell |
170,600
-4,000
| -2% | -$211K | 0.49% | 70 |
|
|
2013
Q3 | $8.7M | Sell |
174,600
-2,000
| -1% | -$96.1K | 0.51% | 68 |
|
|
2013
Q2 | $7.93M | Buy |
+176,600
| New | +$7.72M | 0.48% | 68 |
|
Other funds holding IDXX
EULAV Asset Management's IDXX Position: Q2 2026 in Review
EULAV Asset Management reduced its Idexx Laboratories (IDXX) stake by 70% in Q2 2026, selling an estimated $19.4M and leaving 14,618 shares worth $7.7M. The position accounts for 0.25% of the portfolio, ranked #98.
EULAV Asset Management first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $85.4M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- EULAV Asset Management held 14,618 shares of Idexx Laboratories worth $7.7M as of Q2 2026.
- EULAV Asset Management sold 34,600 Idexx Laboratories shares in Q2 2026, an estimated $19.4M.
- Idexx Laboratories made up 0.25% of EULAV Asset Management's portfolio in Q2 2026, its #98 holding.
- EULAV Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- EULAV Asset Management's Idexx Laboratories position peaked at $85.4M in Q4 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on EULAV Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.